IRME (IR-Med) EBITDA Margin %: 0.00% (As of Jun. 2025)


What is IR-Med EBITDA Margin %?

IR-Med IRME EBITDA Margin % is 0.00% as of Jun. 2025. The stock has 1 warning sign investors should review. Among 816 Medical Devices & Instruments companies, IR-Med ranks worse than 122548.9% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. IR-Med's EBITDA for the three months ended in Jun. 2025 was $-0.28 Mil. IR-Med's Revenue for the three months ended in Jun. 2025 was $0.00 Mil. Therefore, IR-Med's EBITDA margin for the quarter that ended in Jun. 2025 was 0.00%.


IR-Med  (OTCPK:IRME) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


IR-Med EBITDA Margin % Related Terms


IR-Med EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for IR-Med's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IR-Med EBITDA Margin % Chart

IR-Med Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
0.00 0.00 0.00 0.00 0.00

IR-Med Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IRME vs SSKN, NUMD, WOK: EBITDA Margin % Comparison

For the Medical Devices subindustry, IR-Med's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IR-Med EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IR-Med's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where IR-Med's EBITDA Margin % falls into.



IR-Med EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

IR-Med's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-1.92/0
= %

IR-Med's EBITDA Margin % for the quarter that ended in Jun. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-0.282/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
IR-Med (IRME) has a EBITDA Margin % of 0.00% as of Jun. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on IR-Med and its competitors. According to the industry distribution chart, IR-Med ranks #999999 out of 816 companies in the Medical Devices & Instruments industry.
Is IR-Med's EBITDA Margin % too high?
IR-Med's current EBITDA Margin % is 0.00%. Based on the distribution chart, IR-Med ranks #999999 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does IR-Med's EBITDA Margin % compare to SSKN and NUMD?
According to the Medical Devices & Instruments industry distribution chart, IR-Med ranks #999999 out of 816 companies for EBITDA Margin %. This places IR-Med in the lower half of its industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on IR-Med and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IR-Med's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IR-Med stock overvalued right now?
IR-Med (IRME) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For IR-Med (IRME), the current EBITDA Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IR-Med Business Description

Address Z.H.R Industrial Zone, P.O. Box 143, Rosh Pina, ISR, 1231400
IR-Med Inc is a development-stage medical device company that is developing its technology through its Subsidiary and utilizing Infra-Red-light spectroscopy (IR) combined with Artificial Intelligence (AI) technology to develop non-invasive devices for various medical indications. These devices detect and measure biomarkers and molecules in blood and human tissue in real-time.